These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1007759

  • 1. Prostaglandins and prostaglandin precursors as endogenous antiarrhythmic principles of the heart.
    Förster W.
    Acta Biol Med Ger; 1976; 35(8-9):1101-112. PubMed ID: 1007759
    [No Abstract] [Full Text] [Related]

  • 2. [Antiarrhythmic effects of prostaglandin E1, A1 and F2beta against CaCl2- and aconitin-arrhythmias in the rat].
    Mentz P, Förster W.
    Acta Biol Med Ger; 1974; 33(2):245-8. PubMed ID: 4463641
    [No Abstract] [Full Text] [Related]

  • 3. [The anti-arrhythmic effect of prostaglandins A1, E1, A2, E2 and F2a in the cat strophanthin arrhythmia model].
    Mest HJ, Blass KE, Förster W.
    Acta Biol Med Ger; 1976; 35(1):63-7. PubMed ID: 983602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Animal models of cardiac arrhythmias.
    Janse MJ, Opthof T, Kléber AG.
    Cardiovasc Res; 1998 Jul; 39(1):165-77. PubMed ID: 9764198
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The effect of a combination of N-propylajmaline bromide and trimecaine on heart arrhythmias of different origins and on the electrophysiological parameters of the myocardium].
    Gendenshteĭn EI, Balashov VP, Sosunov EA, Kostin IaV, Oleĭnikov VE.
    Farmakol Toksikol; 1991 Jul; 54(4):30-3. PubMed ID: 1786818
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prostaglandins and the heart].
    Pomoĭnetskiĭ VD.
    Ter Arkh; 1980 Jul; 52(6):141-6. PubMed ID: 6250242
    [No Abstract] [Full Text] [Related]

  • 11. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S, Duker G, Carlsson L.
    Prog Biophys Mol Biol; 2008 Jul; 98(2-3):328-39. PubMed ID: 19038282
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM, L'vov MV.
    Farmakol Toksikol; 1970 Jul; 33(3):309-13. PubMed ID: 4393833
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu, Lyskovtsev VV, Senova ZP, Darinskiĭ NV, Grigor'eva EK, Tolmacheva EA, Turilova AI, Gritsenko AN, Kaverina NV.
    Farmakol Toksikol; 1990 Jul; 53(3):33-6. PubMed ID: 2387376
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic properties of Craviten (M-71) in cats and rabbits.
    Chodera A, Banaszkiewicz W, Glinka B.
    Pol J Pharmacol Pharm; 1980 Jul; 32(6):833-40. PubMed ID: 7243680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.